INSM logo

Insmed Incorporated (INSM) EBITDA

Annual EBITDA

-$660.18 M
-$212.81 M-47.57%

December 31, 2023


Summary


Performance

INSM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherINSMprofitabilitymetrics:

Quarterly EBITDA

-$196.45 M
+$80.44 M+29.05%

September 30, 2024


Summary


Performance

INSM Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherINSMprofitabilitymetrics:

TTM EBITDA

-$769.56 M
-$59.94 M-8.45%

September 30, 2024


Summary


Performance

INSM TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherINSMprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

INSM EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-47.6%-43.9%-20.4%
3 y3 years-163.7%-43.9%-20.4%
5 y5 years-123.7%-43.9%-20.4%

INSM EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-72.1%at low-120.2%+29.1%-102.3%at low
5 y5-year-204.1%at low-362.5%+29.1%-283.2%at low
alltimeall time-648.7%at low-262.3%+29.1%-739.6%at low

Insmed Incorporated EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$196.45 M(-29.1%)
-$769.56 M(+8.4%)
Jun 2024
-
-$276.89 M(+107.1%)
-$709.62 M(+8.3%)
Mar 2024
-
-$133.71 M(-17.7%)
-$655.47 M(-0.7%)
Dec 2023
-$660.18 M(+47.6%)
-$162.50 M(+19.0%)
-$660.18 M(+3.3%)
Sep 2023
-
-$136.52 M(-38.7%)
-$639.30 M(+1.7%)
Jun 2023
-
-$222.74 M(+60.9%)
-$628.91 M(+26.7%)
Mar 2023
-
-$138.42 M(-2.3%)
-$496.56 M(+11.0%)
Dec 2022
-$447.37 M(+16.6%)
-$141.63 M(+12.3%)
-$447.37 M(+10.2%)
Sep 2022
-
-$126.13 M(+39.5%)
-$405.91 M(+6.7%)
Jun 2022
-
-$90.39 M(+1.3%)
-$380.33 M(-3.3%)
Mar 2022
-
-$89.22 M(-10.9%)
-$393.13 M(+2.3%)
Dec 2021
-$383.65 M(+53.2%)
-$100.18 M(-0.4%)
-$384.45 M(+2.5%)
Sep 2021
-
-$100.55 M(-2.6%)
-$375.14 M(+14.5%)
Jun 2021
-
-$103.19 M(+28.1%)
-$327.56 M(+19.0%)
Mar 2021
-
-$80.54 M(-11.4%)
-$275.16 M(+9.9%)
Dec 2020
-$250.37 M(+15.3%)
-$90.87 M(+71.6%)
-$250.37 M(+24.0%)
Sep 2020
-
-$52.96 M(+4.3%)
-$201.98 M(+0.6%)
Jun 2020
-
-$50.79 M(-8.9%)
-$200.80 M(-3.3%)
Mar 2020
-
-$55.75 M(+31.2%)
-$207.58 M(-4.4%)
Dec 2019
-$217.07 M(-26.5%)
-$42.48 M(-18.0%)
-$217.07 M(-15.7%)
Sep 2019
-
-$51.78 M(-10.0%)
-$257.61 M(-10.0%)
Jun 2019
-
-$57.56 M(-11.8%)
-$286.31 M(-3.9%)
Mar 2019
-
-$65.24 M(-21.4%)
-$298.01 M(+1.0%)
Dec 2018
-$295.18 M(+59.7%)
-$83.02 M(+3.1%)
-$295.18 M(+7.0%)
Sep 2018
-
-$80.48 M(+16.2%)
-$275.89 M(+15.7%)
Jun 2018
-
-$69.27 M(+11.0%)
-$238.55 M(+12.7%)
Mar 2018
-
-$62.41 M(-2.1%)
-$211.69 M(+14.6%)
Dec 2017
-$184.87 M(+8.6%)
-$63.73 M(+47.7%)
-$184.67 M(-1.3%)
Sep 2017
-
-$43.14 M(+1.7%)
-$187.15 M(+3.8%)
Jun 2017
-
-$42.41 M(+19.8%)
-$180.31 M(+4.1%)
Mar 2017
-
-$35.40 M(-46.5%)
-$173.27 M(+1.8%)
Dec 2016
-$170.24 M(+47.7%)
-$66.21 M(+82.4%)
-$170.24 M(+25.3%)
Sep 2016
-
-$36.29 M(+2.6%)
-$135.88 M(+5.0%)
Jun 2016
-
-$35.37 M(+9.3%)
-$129.36 M(+6.5%)
Mar 2016
-
-$32.37 M(+1.6%)
-$121.44 M(+5.3%)
Dec 2015
-$115.28 M(+33.9%)
-$31.85 M(+7.0%)
-$115.28 M(+8.6%)
Sep 2015
-
-$29.77 M(+8.5%)
-$106.11 M(+6.8%)
Jun 2015
-
-$27.44 M(+4.7%)
-$99.38 M(+5.3%)
Mar 2015
-
-$26.21 M(+15.6%)
-$94.39 M(+9.6%)
Dec 2014
-$86.09 M(+58.8%)
-$22.68 M(-1.5%)
-$86.09 M(+9.2%)
Sep 2014
-
-$23.04 M(+2.6%)
-$78.81 M(+8.9%)
Jun 2014
-
-$22.45 M(+25.3%)
-$72.40 M(+24.8%)
Mar 2014
-
-$17.91 M(+16.3%)
-$58.01 M(+7.0%)
Dec 2013
-$54.20 M(+35.3%)
-$15.40 M(-7.4%)
-$54.20 M(+1.2%)
Sep 2013
-
-$16.63 M(+106.3%)
-$53.57 M(+16.6%)
Jun 2013
-
-$8.06 M(-42.8%)
-$45.96 M(-3.1%)
Mar 2013
-
-$14.11 M(-4.5%)
-$47.45 M(+18.5%)
Dec 2012
-$40.05 M(-32.5%)
-$14.77 M(+63.7%)
-$40.05 M(+20.1%)
Sep 2012
-
-$9.02 M(-5.6%)
-$33.34 M(-43.3%)
Jun 2012
-
-$9.55 M(+42.5%)
-$58.82 M(-0.6%)
Mar 2012
-
-$6.71 M(-16.7%)
-$59.20 M(-0.2%)
DateAnnualQuarterlyTTM
Dec 2011
-$59.31 M(+857.7%)
-$8.05 M(-76.7%)
-$59.31 M(+4.1%)
Sep 2011
-
-$34.51 M(+247.4%)
-$56.99 M(+150.7%)
Jun 2011
-
-$9.94 M(+45.8%)
-$22.74 M(+72.6%)
Mar 2011
-
-$6.81 M(+18.8%)
-$13.18 M(+112.8%)
Dec 2010
-$6.19 M(-105.1%)
-$5.74 M(+2167.2%)
-$6.19 M(+1569.3%)
Sep 2010
-
-$253.00 K(-32.5%)
-$371.00 K(+165.0%)
Jun 2010
-
-$375.00 K(-319.3%)
-$140.00 K(-74.5%)
Mar 2010
-
$171.00 K(+98.8%)
-$550.00 K(-100.5%)
Dec 2009
$120.31 M(-1000.0%)
$86.00 K(-490.9%)
$120.31 M(+3.1%)
Sep 2009
-
-$22.00 K(-97.2%)
$116.72 M(+1.4%)
Jun 2009
-
-$785.00 K(-100.6%)
$115.11 M(+3.0%)
Mar 2009
-
$121.04 M(-3550.3%)
$111.73 M(-908.8%)
Dec 2008
-$13.37 M(-33.3%)
-$3.51 M(+114.6%)
-$13.81 M(+2.3%)
Sep 2008
-
-$1.64 M(-60.7%)
-$13.50 M(-15.1%)
Jun 2008
-
-$4.17 M(-7.6%)
-$15.90 M(+11.8%)
Mar 2008
-
-$4.51 M(+40.9%)
-$14.22 M(-29.0%)
Dec 2007
-$20.03 M(-60.7%)
-$3.20 M(-20.7%)
-$20.03 M(-47.0%)
Sep 2007
-
-$4.03 M(+62.4%)
-$37.77 M(-18.6%)
Jun 2007
-
-$2.48 M(-75.9%)
-$46.37 M(-12.7%)
Mar 2007
-
-$10.32 M(-50.7%)
-$53.13 M(+4.2%)
Dec 2006
-$51.00 M(+250.9%)
-$20.93 M(+65.7%)
-$51.00 M(+62.0%)
Sep 2006
-
-$12.64 M(+36.7%)
-$31.48 M(+49.4%)
Jun 2006
-
-$9.24 M(+12.8%)
-$21.07 M(+20.9%)
Mar 2006
-
-$8.19 M(+482.0%)
-$17.43 M(+19.9%)
Dec 2005
-$14.54 M(-46.9%)
-$1.41 M(-36.8%)
-$14.54 M(-23.5%)
Sep 2005
-
-$2.23 M(-60.2%)
-$19.01 M(-22.2%)
Jun 2005
-
-$5.60 M(+5.8%)
-$24.42 M(-12.4%)
Mar 2005
-
-$5.30 M(-9.9%)
-$27.87 M(+1.7%)
Dec 2004
-$27.39 M(+161.1%)
-$5.88 M(-23.0%)
-$27.39 M(+14.1%)
Sep 2004
-
-$7.64 M(-15.6%)
-$24.00 M(+27.6%)
Jun 2004
-
-$9.05 M(+87.7%)
-$18.80 M(+44.2%)
Mar 2004
-
-$4.82 M(+93.7%)
-$13.04 M(+24.3%)
Dec 2003
-$10.49 M(-69.3%)
-$2.49 M(+1.8%)
-$10.49 M(-60.6%)
Sep 2003
-
-$2.44 M(-25.6%)
-$26.60 M(+1.0%)
Jun 2003
-
-$3.29 M(+44.6%)
-$26.34 M(-12.8%)
Mar 2003
-
-$2.27 M(-87.8%)
-$30.23 M(-11.5%)
Dec 2002
-$34.15 M(-11.6%)
-$18.60 M(+750.6%)
-$34.15 M(+34.9%)
Sep 2002
-
-$2.19 M(-69.5%)
-$25.32 M(-20.2%)
Jun 2002
-
-$7.17 M(+15.7%)
-$31.74 M(-6.2%)
Mar 2002
-
-$6.19 M(-36.7%)
-$33.85 M(-12.4%)
Dec 2001
-$38.64 M(+27.5%)
-$9.78 M(+13.5%)
-$38.64 M(-398.4%)
Sep 2001
-
-$8.61 M(-7.1%)
$12.95 M(-20.7%)
Jun 2001
-
-$9.27 M(-15.7%)
$16.34 M(-154.6%)
Mar 2001
-
-$10.99 M(-126.3%)
-$29.90 M(-1.3%)
Dec 2000
-$30.31 M(+276.9%)
$41.82 M(-900.2%)
-$30.31 M(-58.0%)
Sep 2000
-
-$5.23 M(-90.6%)
-$72.13 M(+7.8%)
Jun 2000
-
-$55.51 M(+387.0%)
-$66.90 M(+412.5%)
Mar 2000
-
-$11.40 M(+587.8%)
-$13.05 M(+305.7%)
Dec 1999
-$8.04 M
-
-
Jun 1999
-
-$1.66 M(+6.1%)
-$3.22 M(+106.1%)
Mar 1999
-
-$1.56 M
-$1.56 M

FAQ

  • What is Insmed Incorporated annual EBITDA?
  • What is the all time high annual EBITDA for Insmed Incorporated?
  • What is Insmed Incorporated annual EBITDA year-on-year change?
  • What is Insmed Incorporated quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Insmed Incorporated?
  • What is Insmed Incorporated quarterly EBITDA year-on-year change?
  • What is Insmed Incorporated TTM EBITDA?
  • What is the all time high TTM EBITDA for Insmed Incorporated?
  • What is Insmed Incorporated TTM EBITDA year-on-year change?

What is Insmed Incorporated annual EBITDA?

The current annual EBITDA of INSM is -$660.18 M

What is the all time high annual EBITDA for Insmed Incorporated?

Insmed Incorporated all-time high annual EBITDA is $120.31 M

What is Insmed Incorporated annual EBITDA year-on-year change?

Over the past year, INSM annual EBITDA has changed by -$212.81 M (-47.57%)

What is Insmed Incorporated quarterly EBITDA?

The current quarterly EBITDA of INSM is -$196.45 M

What is the all time high quarterly EBITDA for Insmed Incorporated?

Insmed Incorporated all-time high quarterly EBITDA is $121.04 M

What is Insmed Incorporated quarterly EBITDA year-on-year change?

Over the past year, INSM quarterly EBITDA has changed by -$59.94 M (-43.90%)

What is Insmed Incorporated TTM EBITDA?

The current TTM EBITDA of INSM is -$769.56 M

What is the all time high TTM EBITDA for Insmed Incorporated?

Insmed Incorporated all-time high TTM EBITDA is $120.31 M

What is Insmed Incorporated TTM EBITDA year-on-year change?

Over the past year, INSM TTM EBITDA has changed by -$130.25 M (-20.37%)